Is Gel Nail Polish Banned? The Truth on HEMA Restrictions

The European Union is preparing to implement one of the most significant regulatory actions against cosmetic nail products in modern history. Beginning September 1, 2025, the EU will ban two key ingredients commonly found in gel nail polishes: HEMA (2-hydroxyethyl methacrylate) and TPO (trimethylbenzoyl diphenylphosphine oxide). The restrictions target substances linked to allergic reactions, skin sensitization, and reproductive health concerns, marking a decisive shift in how nail products are regulated worldwide.

The upcoming ban represents a precautionary approach by European regulators, who have determined that even low concentrations of these substances pose unacceptable risks to both consumers and nail professionals. While the regulations apply specifically within EU borders, their impact is expected to reverberate across global markets as manufacturers reformulate products to meet stricter safety standards.

For millions of people who regularly use gel nail polish, the changes raise important questions about product safety, availability, and what alternatives exist. Understanding the scope of these restrictions—and what they mean for everyday use—requires examining the specific ingredients involved, the health concerns driving the regulations, and how different regions are responding to emerging safety evidence.

Is Gel Nail Polish Banned?

The answer depends on where you live and what specific products you use. Gel nail polish itself is not being banned entirely; rather, regulations target specific ingredients found in many formulations. In the European Union, products containing HEMA or TPO will be prohibited from sale starting September 1, 2025. The United Kingdom is expected to follow with similar restrictions on TPO by 2026. In the United States, however, neither ingredient is currently banned, and both remain permitted in cosmetic products available to consumers.

Gel Nail Polish Ban at a Glance

Key Takeaways

• The EU ban focuses on two specific ingredients rather than gel nail polish as a product category
• HEMA is restricted due to its role as a leading cause of allergic contact dermatitis among nail product users
• TPO faces prohibition because of its classification as a CMR 1B substance (carcinogenic, mutagenic, or toxic to reproduction)
• The US Food and Drug Administration has not enacted bans on either ingredient, though a November 2024 Cosmetic Ingredient Review noted fertility concerns related to TPO
• Many manufacturers had already begun transitioning to HEMA-free formulations before the official ban date
• Professional nail technicians face higher exposure risks due to repeated contact with these substances
• The restrictions apply to both professional-use and over-the-counter products containing the targeted ingredients

Quick Facts Table

Why Is Gel Nail Polish Being Banned?

The restrictions stem from mounting evidence that certain chemical ingredients in gel polishes pose significant health risks, particularly with repeated exposure. Both HEMA and TPO have been scrutinized for distinct but serious concerns that European regulators determined warranted immediate action rather than continued monitoring.

Health Risks Associated with HEMA

HEMA functions as a bonding agent in gel nail polishes, helping the product adhere to the nail surface and create the durable finish that makes these products so popular. However, this same chemical property means that HEMA can easily penetrate the skin, particularly during application or when improper curing leaves residual product on the nails.

According to available research and regulatory assessments, HEMA ranks among the leading causes of allergic contact dermatitis in both nail professionals and their clients. Studies indicate that sensitization rates among regular gel polish users exceed ten percent, with the risk increasing substantially for those who work with these products professionally. Once sensitization occurs, individuals may develop permanent allergic reactions not only to nail products but potentially to other consumer goods containing similar methacrylate compounds.

Health Risks Associated with TPO

TPO serves as a photoinitiator, the compound that allows gel polishes to cure under UV or LED light. Without this ingredient, the rapid hardening process that makes gel nails so practical would not be possible. TPO’s effectiveness in this role is well-established, but its safety profile has raised significant concerns among regulators.

The European Union has classified TPO as a CMR 1B substance—standing for carcinogenic, mutagenic, or toxic to reproduction. This classification triggers automatic restrictions under EU cosmetics regulations regardless of concentration levels. Research cited by regulatory bodies includes animal studies suggesting potential fertility impacts, though the US Cosmetic Ingredient Review panel found insufficient evidence to classify TPO as carcinogenic in its November 2024 assessment.

Broader Concerns with Methacrylate Compounds

Beyond the two banned ingredients, health professionals have expressed concerns about methacrylate compounds more generally. The process of curing gel polishes under UV light introduces additional considerations, as the light exposure itself may affect skin health. Combined with the frequency of gel nail applications and the proximity of UV lamps to the skin, these factors create a complex exposure profile that regulators are increasingly scrutinizing.

Nail professionals face particular vulnerability due to repeated daily exposure. Before the full ban takes effect, the EU had already restricted HEMA and di-HEMA TMHDC to professional-use products only, requiring prominent “For professional use only” warnings. This compromise acknowledged both the legitimate professional use cases and the elevated risks associated with frequent handling of these substances.

What Is HEMA and Which Gel Polishes Are Affected?

Understanding which products fall under the new restrictions requires recognizing HEMA and TPO by name and function. HEMA, or 2-hydroxyethyl methacrylate, belongs to the methacrylate family of compounds widely used in dental materials, medical adhesives, and cosmetic nail products. Its ability to form strong bonds while remaining relatively inexpensive has made it a staple ingredient in gel formulations for decades.

To learn more about the specific health concerns driving these restrictions, explore our detailed guide on Is HEMA Nail Polish Banned?

Where HEMA Appears in Products

HEMA functions primarily as an adhesion promoter in gel polishes. It helps the product bond to the nail plate and contributes to the characteristic durability that distinguishes gel manicures from traditional nail polish. This ingredient appears across a wide range of products, from budget-friendly drugstore options to professional-grade salon supplies.

TPO, or trimethylbenzoyl diphenylphosphine oxide, operates through a different mechanism. As a photoinitiator, it absorbs light energy and triggers the chemical reaction that hardens the gel. Different photoinitiators cure at different wavelengths, and TPO was favored for its effectiveness under both UV and LED light sources commonly used in nail salons.

Professional Versus Consumer Products

The affected products span both professional and consumer categories. Prior to the full ban, the EU required that products containing HEMA or di-HEMA TMHDC carry clear professional-use warnings. However, enforcement across the wide range of available products has been inconsistent, and many consumers have used these formulations without realizing they contained restricted substances.

The September 2025 ban removes this distinction, prohibiting all gel nail products containing HEMA or TPO regardless of labeling or intended user category. This comprehensive approach ensures that no new products with these ingredients enter the European market, though existing stocks may continue to be used for a limited period.

Timeline of the Gel Nail Polish Restrictions

The regulatory journey leading to the upcoming ban spans several years of scientific review, public consultation, and policy deliberation. Understanding this progression provides context for why these specific restrictions are now taking effect and what timeline consumers and industry professionals should anticipate.

Regulatory Timeline

1. November 2024 — The Cosmetic Ingredient Review panel in the United States publishes its assessment of TPO, concluding that while the ingredient is not carcinogenic, concerns about potential fertility effects warrant further attention. This report represents the most recent comprehensive scientific evaluation available in the US context.
2. December 2023 — Following extended review periods, EU regulators finalize the proposed restrictions on HEMA and TPO in cosmetic nail products. The decision reflects accumulated evidence from allergy reports, professional exposure studies, and precautionary considerations regarding CMR classification.
3. 2023 — Scientific Committee on Consumer Safety opinions inform the regulatory proposal, establishing the foundation for restrictions based on documented sensitization rates and potential reproductive health impacts.
4. Early 2023 — Industry groups receive notification of impending restrictions, allowing time for reformulation efforts and inventory management. Trade associations note that no viable alternative to TPO had been proven safe and effective, creating challenges for certain product categories.
5. September 1, 2025 — The full EU ban takes effect. All gel nail products containing HEMA or TPO are prohibited from sale within EU member states regardless of intended use category.
6. 2026 — The United Kingdom is expected to implement its own ban on TPO, following a similar precautionary regulatory approach to the EU. Details of this restriction continue to be developed.

Implementation Considerations

The transition period between announcement and enforcement has allowed manufacturers varying degrees of time to adapt. Some brands had already developed HEMA-free formulations before regulations required it, positioning themselves for the shift. Others have scrambled to identify suitable alternatives while maintaining product performance expectations.

Consumer access to compliant products is improving as the ban date approaches. However, some professional nail technicians report challenges in sourcing certain specialized formulations, particularly those requiring specific curing characteristics that TPO uniquely provides.

HEMA-Free Alternatives to Gel Nail Polish

The transition away from HEMA and TPO has accelerated development of alternative formulations that maintain the desirable characteristics of gel polish while eliminating problematic ingredients. Manufacturers have invested significantly in research to identify compounds that provide adhesion, durability, and curing efficiency without the health concerns associated with restricted substances.

Available Alternatives

Brands now offer HEMA-free and TPO-free gel polishes that use different adhesion monomers and curing agents. These formulations typically rely on alternative methacrylate compounds that demonstrate lower sensitization potential while still achieving strong bonding and durability. Many also market themselves with additional appeal such as vegan and cruelty-free certification. For those interested in the specifics of these regulations, you can find a fake banknotes police warning detailing the HEMA restrictions on gel nail polish.

Specific brands have positioned themselves at the forefront of the transition. YouGel has maintained 100% HEMA-free and TPO-free formulations since well before the regulatory deadline. MissGel provides guidance resources to help both professionals and consumers navigate compliance requirements and identify safe alternatives.

For additional information on transitioning to safer nail products and understanding the latest regulatory developments, visit our comprehensive resource on HEMA restrictions.

Market Response and Consumer Trends

Demand for HEMA-free products has grown substantially in the United States even without regulatory mandates. American salons report increasing numbers of clients specifically requesting alternatives, suggesting that awareness of the health concerns has influenced consumer behavior independently of legal requirements.

Making the Switch

Consumers wishing to transition to compliant products should check ingredient labels carefully and research specific brands’ formulation policies. Many retailers now highlight HEMA-free status prominently in product descriptions and marketing materials. Patch testing remains advisable when trying any new nail product, as individual sensitivities can vary.

Professional nail technicians considering reformulation of their service offerings should review their current product inventories, identify affected items, and research compatible alternatives that meet their performance requirements. Many distributors have provided guidance documents to assist with this transition.

Facts Versus Uncertainties

Navigating the information surrounding gel nail polish regulations requires distinguishing between established facts and areas where scientific understanding or regulatory clarity remains incomplete. This distinction helps stakeholders make informed decisions while recognizing the limitations of current knowledge.

Understanding the Regulatory Context

The gel nail polish restrictions represent one facet of broader efforts to reassess the safety of methacrylate compounds in consumer products. These chemicals have served industrial and medical purposes for decades, with applications ranging from dental fillings to surgical adhesives. The nail care industry adopted them relatively recently by historical standards, and accumulating real-world usage data has revealed allergy patterns that earlier safety assessments did not anticipate.

The EU’s precautionary regulatory framework allows restrictions based on potential risks rather than requiring proof of actual harm. This approach particularly influences decisions regarding reproductive health, where waiting for conclusive human evidence would be ethically problematic given the severity of potential outcomes. The CMR 1B classification for TPO reflects this precautionary stance, automatically triggering restrictions for substances demonstrating relevant effects in animal studies.

Different regulatory philosophies across jurisdictions create a complex global landscape for manufacturers and consumers. Products legal in one country may face prohibition in another, complicating international commerce and leaving consumers to navigate varying safety standards. For US consumers, the absence of restrictions means continued access to existing products, though awareness of the concerns driving EU policy may influence personal choices.

Looking Ahead

The September 2025 implementation date represents a turning point for the nail care industry, but the regulatory evolution is unlikely to stop there. Observers anticipate that additional countries may develop their own frameworks for addressing methacrylate concerns, potentially following the EU’s lead in restricting problematic ingredients.

Innovation in formulation chemistry continues, with research ongoing into alternative photoinitiators and adhesion compounds that might provide gel polish’s desirable characteristics without the associated health concerns. Consumer preference for safer products is already driving market changes even in regions without mandates, suggesting that voluntary reformulation may proceed regardless of regulatory requirements.

For now, consumers in the EU and UK will need to verify that their gel polish products meet updated safety standards, while those in other regions have the option of seeking alternatives or continuing with existing products. Staying informed about ingredient lists and regulatory developments remains the most practical approach to navigating these changes.

Frequently Asked Questions